CAS 74713-59-0|C8-Ceramide
| Common Name | C8-Ceramide | ||
|---|---|---|---|
| CAS Number | 74713-59-0 | Molecular Weight | 425.688 |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 595.5±50.0 °C at 760 mmHg |
| Molecular Formula | C26H51NO3 | Melting Point | 68-70°C |
| MSDS | ChineseUSA | Flash Point | 313.9±30.1 °C |
Names
| Name | c8 ceramide |
|---|---|
| Synonym | More Synonyms |
C8-Ceramide BiologicalActivity
| Description | C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections. C8-Ceramide induces slight activation of protein kinase (PKC) in vitro[1][2][3][4]. |
|---|---|
| Related Catalog | Signaling Pathways >>Apoptosis >>ApoptosisSignaling Pathways >>Epigenetics >>PKCResearch Areas >>CancerSignaling Pathways >>Autophagy >>AutophagyResearch Areas >>Inflammation/ImmunologySignaling Pathways >>TGF-beta/Smad >>PKC |
| Target | PKC apoptosis autophagy |
| In Vitro | C8-ceramide (3 μM; 48 hours) irreversibly reduces tumor-cell proliferation and induces morphological changes[1]. C8-ceramide can induce necrosis-like cell death, but does not induce caspase-dependent cleavage of PARP (biochemical marker of apoptosis) in human cervical tumor cells[1]. C8-ceramide may increase the endogenous ROS level (10-30 µM; 24 hours) by regulating the switch of SOD1 and SOD2, causing the anti-proliferation (10-50 µM; 24 hours), and consequently triggering the apoptosis (10-50 µM; 48 hours) of NSCLC H1299 cells[2]. Cell Viability Assay[1] Cell Line: CALO cells, INBL cells, HeLa cells Concentration: 3 μM Incubation Time: 48 hours Result: Markedly reduced the tumor cell number. Cell Proliferation Assay[2] Cell Line: H1299 cells Concentration: 10 µM, 20 µM, 30 µM, 40 µM, 50 µM Incubation Time: 24 hours Result: Decreased the rate of cellular proliferation in a dose-dependent manner, with an IC50 of 22.9 µM. Cell Cycle Analysis[2] Cell Line: H1299 cells Concentration: 10 µM, 20 µM, 30 µM, 40 µM, 50 µM Incubation Time: 24 hours Result: Caused the G1 arrest. Apoptosis Analysis[2] Cell Line: H1299 cells Concentration: 10 µM, 20 µM, 30 µM Incubation Time: 24 hours, 48 hours Result: Increased the level of cleaved caspase-3. |
| In Vivo | C8-ceramide (0.1 mg/kg; intranasal administration) induces more robust CD8+ and CD4+ T cell responses to viral infections in virus infected mice[3]. Animal Model: C57BL/6 mice, with lymphocytic choriomeningitis virus infected[2] Dosage: 0.1 mg/kg Administration: Intranasal administration Result: Increased the CD8+ T cell response to influenza in the lungs. |
| References | [1]. Rebeca López-Marure , et al. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun. 2002 May 10;293(3):1028-36. [2]. Yuli C. Chang, et al. Exogenous C8-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells. Int J Mol Sci. 2018 Oct; 19(10): 3010. [3]. Curtis J. Pritzl, et al. A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections. J Immunol. 2015 May 1; 194(9): 4339–4349. [4]. H W Huang, et al. Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers. Biophys J. 1999 Sep; 77(3): 1489–1497. [5]. Lan Weiss, et al. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum Mol Genet. 2021 Jan 7;ddaa248. |
Chemical & Physical Properties
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 595.5±50.0 °C at 760 mmHg |
| Melting Point | 68-70°C |
| Molecular Formula | C26H51NO3 |
| Molecular Weight | 425.688 |
| Flash Point | 313.9±30.1 °C |
| Exact Mass | 425.386902 |
| PSA | 69.56000 |
| LogP | 9.09 |
| Appearance of Characters | waxy solid |
| Vapour Pressure | 0.0±3.8 mmHg at 25°C |
| Index of Refraction | 1.482 |
| InChIKey | APDLCSPGWPLYEQ-WRBRXSDHSA-N |
| SMILES | CCCCCCCCCCCCCC=CC(O)C(CO)NC(=O)CCCCCCC |
| Storage condition | −20°C |
| Stability | Temperature Sensitive |
| Water Solubility | DMSO or ethanol: soluble |
Safety Information
| Safety Phrases | S24/25 |
|---|---|
| WGK Germany | 3 |
| HS Code | 2924199090 |
Customs
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Synonyms
| 08:0 CERAMIDE |
| C8-D-ERYTHRO-CERAMIDE |
| N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl]octanamide |
| CERAMIDE C8 |
| N-Octanoyl-C18-sphingosine |
| MFCD00236496 |
| Octanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]- |
| C8 CERAMINE,D-ERYTHRO |
| N-OCTANOYL-D-SPHINGOSINE |
| N-Octanoyl-D-erythro-sp |
| N-OCTANOYLSPHINGOSINE |
| N-Octanoyl-D-erythr |
| N-octanoyl-D-erythro-sphingosine |
